Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Argus Health
McKinsey
Daiichi Sankyo
US Army
Express Scripts
Teva
Cerilliant
Johnson and Johnson
Queensland Health

Generated: December 11, 2017

DrugPatentWatch Database Preview

HEPARIN SODIUM IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

When do Heparin Sodium In Plastic Container patents expire, and what generic alternatives are available?

Heparin Sodium In Plastic Container is a drug marketed by Fresenius Kabi Usa and is included in one NDA.

The generic ingredient in HEPARIN SODIUM IN PLASTIC CONTAINER is heparin sodium. There are seventy-seven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.

Summary for HEPARIN SODIUM IN PLASTIC CONTAINER

Drug patent expirations by year for HEPARIN SODIUM IN PLASTIC CONTAINER

Pharmacology for HEPARIN SODIUM IN PLASTIC CONTAINER

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi UsaHEPARIN SODIUM IN PLASTIC CONTAINERheparin sodiumINJECTABLE;INJECTION017029-013Dec 5, 1985APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaHEPARIN SODIUM IN PLASTIC CONTAINERheparin sodiumINJECTABLE;INJECTION017029-016Dec 5, 1985APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaHEPARIN SODIUM IN PLASTIC CONTAINERheparin sodiumINJECTABLE;INJECTION017029-014Dec 5, 1985APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaHEPARIN SODIUM IN PLASTIC CONTAINERheparin sodiumINJECTABLE;INJECTION017029-015Dec 5, 1985APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Chinese Patent Office
Teva
Medtronic
UBS
Cerilliant
QuintilesIMS
McKinsey
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot